Scholars@Duke

Pharmacologic Treatments in Adults With Type 2 Diabetes: Cost-Effectiveness and Comorbidity Considerations.

Publication ,  Journal Article
Syed, FZ
Published in: Ann Intern Med
May 2024
Published version (DOI) Link to item

Duke Scholars

Fatima Zahara Syed
Author Fatima Zahara Syed Medicine, General Internal Medicine

Published In

Ann Intern Med

DOI

10.7326/M24-0861

EISSN

1539-3704

Publication Date

May 2024

Volume

177

Issue

5

Start / End Page

680 / 681

Location

United States

Related Subject Headings

  • Hypoglycemic Agents
  • Humans
  • General & Internal Medicine
  • Diabetes Mellitus, Type 2
  • Cost-Benefit Analysis
  • Comorbidity
  • Adult
  • 3202 Clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Syed, F. Z. (2024). Pharmacologic Treatments in Adults With Type 2 Diabetes: Cost-Effectiveness and Comorbidity Considerations. Ann Intern Med, 177(5), 680–681. https://doi.org/10.7326/M24-0861
Syed, Fatima Z. “Pharmacologic Treatments in Adults With Type 2 Diabetes: Cost-Effectiveness and Comorbidity Considerations.” Ann Intern Med 177, no. 5 (May 2024): 680–81. https://doi.org/10.7326/M24-0861.
Syed, Fatima Z. “Pharmacologic Treatments in Adults With Type 2 Diabetes: Cost-Effectiveness and Comorbidity Considerations.” Ann Intern Med, vol. 177, no. 5, May 2024, pp. 680–81. Pubmed, doi:10.7326/M24-0861.

Published In

Ann Intern Med

DOI

10.7326/M24-0861

EISSN

1539-3704

Publication Date

May 2024

Volume

177

Issue

5

Start / End Page

680 / 681

Location

United States

Related Subject Headings

  • Hypoglycemic Agents
  • Humans
  • General & Internal Medicine
  • Diabetes Mellitus, Type 2
  • Cost-Benefit Analysis
  • Comorbidity
  • Adult
  • 3202 Clinical sciences
  • 11 Medical and Health Sciences